UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): May 1, 2017 (April 27, 2017)

PFIZER INC.

(Exact name of registrant as specified in its charter)

Delaware

1-3619

13-5315170

(State or other Jurisdiction of incorporation)

(Commission File Number)

(I.R.S. Employer Identification No.)

235 East 42nd Street

New York, New York

(Address of principal executive offices)

10017

(Zip Code)

Registrant's telephone number, including area code:

(212) 733-2323

Not Applicable

(Former Name or Former Address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended

to simultaneously satisfy the obligation of the registrant under any of the

following provisions (see General Instruction A.2. below):

[ ] Written communication pursuant to Rule 425 under the Securities

Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange

Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b)

under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c)

under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company

as defined in Rule 405 of the Securities Act of 1933 ( 230.405 of this chapter)

or Rule 12b-2 of the Securities Exchange Act of 1934 ( 240.12b-2 of this

chapter).

Emerging growth company [ ]

If an

emerging growth company, indicate by check mark if the registrant has elected

not to use the extended transition period for complying with any new or revised

financial accounting standards pursuant to Section 13(a) of the Exchange Act.

[ ]

Item 5.07

Submission of Matters to a Vote of Security Holders

(a) The Pfizer Inc. (the "Company") Annual Meeting of Shareholders was held on April 27, 2017.

(b) Shareholders voted on the matters set forth below.

1. The nominees for election to the Company’s Board of Directors

were elected to hold office until the Company’s next Annual Meeting of Shareholders, based upon the following votes:

Nominee

Votes For

Votes Against

Abstentions

Broker non-votes

Dennis A. Ausiello

4,152,501,049

75,514,314

13,839,358

922,977,815

Ronald E. Blaylock

4,164,933,510

62,636,919

14,294,069

922,977,815

W. Don Cornwell

4,027,032,793

200,454,995

14,382,843

922,977,815

Joseph J. Echevarria

4,175,460,147

52,326,845

14,082,675

922,977,815

Frances D. Fergusson

4,183,313,416

44,564,457

13,993,585

922,977,815

Helen H. Hobbs

4,203,418,078

25,415,701

13,037,680

922,977,815

James M. Kilts

3,428,377,699

788,781,156

24,712,604

922,977,815

Shantanu Narayen

4,187,489,160

40,233,206

14,148,394

922,977,815

Suzanne Nora Johnson

4,158,446,107

70,141,723

13,281,430

922,977,815

Ian C. Read

4,011,974,954

179,295,677

50,592,617

922,977,815

Stephen W. Sanger

4,106,265,694

97,150,063

38,455,076

922,977,815

James C. Smith

4,182,841,733

44,129,277

14,899,823

922,977,815

2. The proposal to ratify the selection of KPMG LLP as the Company’s independent registered public accounting firm for the 2017 fiscal year

was approved based upon the following votes:

Votes for approval

5,018,058,421

Votes against

127,091,711

Abstentions

19,697,878

Broker non-votes

N/A

3. The proposal to

approve, on an advisory basis, executive compensation was approved based

upon the following votes:

Votes for approval

3,941,679,516

Votes against

269,008,927

Abstentions

31,184,241

Broker non-votes

922,977,815

4. The proposal

on the frequency of future advisory votes on executive compensation

received the following votes:

For 3 years

526,554,428

For 2 years

24,985,010

For 1 Year

3,669,882,602

Abstentions

20,344,405

Broker non-votes

922,977,815

5. The shareholder proposal

regarding The Holy Land Principles was withdrawn by the proponent and not presented at

the Annual Meeting.

6. The shareholder proposal regarding

special shareowner meetings was not approved based upon the following votes:

Votes for approval

1,941,978,794

Votes against

2,266,430,971

Abstentions

33,453,959

Broker non-votes

922,977,815

7. The shareholder

proposal regarding independent chair policy was not approved based upon the following votes:

Votes for approval

1,086,656,978

Votes against

3,122,212,329

Abstentions

32,981,454

Broker non-votes

922,977,815

(c) Not applicable.

(d) Based upon the results

set forth in item (b) (4) above, and consistent with the Board's recommendation, the Board of Directors has determined that

advisory votes on executive compensation will be submitted to shareholders

on an annual basis until the next required vote on the frequency of such

votes.

SIGNATURE

Under the requirements of the Securities Exchange Act of 1934, the registrant

has caused this report to be signed on its behalf by the authorized undersigned.

PFIZER INC.

Dated: May 1, 2017

By: /s/ Margaret M. Madden

Margaret M. Madden

Title: Senior Vice President & Corporate Secretary

Chief Governance Counsel